New grad roles at Lyell Immunopharma
Lyell Immunopharma is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies for cancer. Its programs target hematologic malignancies and solid tumors, with a focus on improving T-cell potency, persistence, tumor infiltration, and durable clinical response.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 3
No current roles
Check back soon.
Get new Lyell Immunopharma new grad roles by email
Free account. Get new Lyell Immunopharma new grad roles by email or push the minute they post.
